The Canadian Cancer Trials Group (CCTG) is an academic cooperative oncology group that designs and conducts clinical trials testing cancer therapy, supportive care and prevention interventions across Canada. The Group is a collaborative network of researchers, physicians, scientists, statisticians and patients internationally recognized for finding the treatments that give people with cancer longer, better quality lives.

Created in 1980, the group has run trials resulting in major, life-saving breakthroughs in breast, colorectal, blood, lung, ovarian, brain and prostate cancer. The network is made of more than 85 member institutions, comprising over 2,100 Canadian investigators working with 4,400 clinical trial staff and has facilitated over 600 trials. Globally, CCTG has worked with more than 20,000 collaborators and clinical trial professionals in 40 countries on 6 continents. Most importantly are the approximately 3,000 patient volunteers per year who participate in our trials in order to potentially receive better treatments that could also benefit others in the future.

CCTG’s Operations and Statistics Centre is located in the Sinclair Cancer Research Institute at Queen’s University, with in-house faculty researchers that include clinician scientists, researchers in community health and epidemiology, and biostatisticians.

The group is proud to be one of the national programmes of the Canadian Cancer Society (CCS), the only non-American partner of the US National Clinical Trials Network and collaborators with research cooperative groups around the world. These international partnerships are central to the success of their cancer clinical trials and crucial to the advancement of the cancer research agenda in Canada.

Find out more:

• Clinical trials for game-changing cancer research
• CCTG at Queen's plays a central role in the progress of cancer care